Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Rebecca CHARLTON |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Aging and autism: Do measures of autism symptoms, co-occurring mental health conditions, or quality of life differ between younger and older autistic adults? / Esra ZÄ+vralÄ+ YARAR in Autism Research, 15-8 (August 2022)
[article]
Titre : Aging and autism: Do measures of autism symptoms, co-occurring mental health conditions, or quality of life differ between younger and older autistic adults? Type de document : Texte imprimé et/ou numérique Auteurs : Esra ZÄ+vralÄ+ YARAR, Auteur ; Amanda ROESTORF, Auteur ; Debbie SPAIN, Auteur ; Patricia HOWLIN, Auteur ; Dermot BOWLER, Auteur ; Rebecca CHARLTON, Auteur ; Francesca HAPPE, Auteur Article en page(s) : p.1482-1494 Langues : Anglais (eng) Mots-clés : Adult Aging Autism Spectrum Disorder/complications/epidemiology/psychology Autistic Disorder/complications/epidemiology/psychology Cross-Sectional Studies Humans Mental Health Quality of Life/psychology adults autism spectrum disorder quality of life Index. décimale : PER Périodiques Résumé : Previous research has indicated that autistic adults experience higher rates of co-occurring mental health difficulties and poorer quality of life (QoL) than their non-autistic peers. Little is known, however, about these aspects in older age or whether younger and older autistic adults experience similar patterns This cross-sectional study investigated potential age-related effects on autism symptoms, self-reported mental health, and QoL in younger and older autistic adults (n = 79, aged 19-71years) compared to a non-autistic control group (n = 57) matched for gender, age and IQ. Results showed that autistic adults had higher levels of self-reported autism symptoms and poorer QoL than controls. There were no significant age effects on autism symptoms or on most self-rated mental health symptoms. However, significantly more autistic adults in the younger versus older group scored above the clinical threshold for anxiety, somatoform disorders and eating disorders. Older autistic adults rated social QoL as significantly better than younger autistic adults; there was no significant age difference in the control group. Self-reported QoL was best predicted by self-ratings of severity of depressive symptoms in both groups. Further research is needed to track autism and co-occurring mental health symptomatology across the lifespan, so that service provision can be tailored accordingly. LAY SUMMARY: Young autistic adults have reported more psychological difficulties and poorer quality of life (QoL) than the general population. We investigated whether these difficulties continue into older age. Autism symptoms and mental health problems were common in autistic adults, with no difference between age groups, except for anxiety, physical and eating problems. Although QoL was poorer in both younger and older autistic compared to non-autistic adults, older autistic adults reported better social QoL than those who were younger. En ligne : http://dx.doi.org/10.1002/aur.2780 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=483
in Autism Research > 15-8 (August 2022) . - p.1482-1494[article] Aging and autism: Do measures of autism symptoms, co-occurring mental health conditions, or quality of life differ between younger and older autistic adults? [Texte imprimé et/ou numérique] / Esra ZÄ+vralÄ+ YARAR, Auteur ; Amanda ROESTORF, Auteur ; Debbie SPAIN, Auteur ; Patricia HOWLIN, Auteur ; Dermot BOWLER, Auteur ; Rebecca CHARLTON, Auteur ; Francesca HAPPE, Auteur . - p.1482-1494.
Langues : Anglais (eng)
in Autism Research > 15-8 (August 2022) . - p.1482-1494
Mots-clés : Adult Aging Autism Spectrum Disorder/complications/epidemiology/psychology Autistic Disorder/complications/epidemiology/psychology Cross-Sectional Studies Humans Mental Health Quality of Life/psychology adults autism spectrum disorder quality of life Index. décimale : PER Périodiques Résumé : Previous research has indicated that autistic adults experience higher rates of co-occurring mental health difficulties and poorer quality of life (QoL) than their non-autistic peers. Little is known, however, about these aspects in older age or whether younger and older autistic adults experience similar patterns This cross-sectional study investigated potential age-related effects on autism symptoms, self-reported mental health, and QoL in younger and older autistic adults (n = 79, aged 19-71years) compared to a non-autistic control group (n = 57) matched for gender, age and IQ. Results showed that autistic adults had higher levels of self-reported autism symptoms and poorer QoL than controls. There were no significant age effects on autism symptoms or on most self-rated mental health symptoms. However, significantly more autistic adults in the younger versus older group scored above the clinical threshold for anxiety, somatoform disorders and eating disorders. Older autistic adults rated social QoL as significantly better than younger autistic adults; there was no significant age difference in the control group. Self-reported QoL was best predicted by self-ratings of severity of depressive symptoms in both groups. Further research is needed to track autism and co-occurring mental health symptomatology across the lifespan, so that service provision can be tailored accordingly. LAY SUMMARY: Young autistic adults have reported more psychological difficulties and poorer quality of life (QoL) than the general population. We investigated whether these difficulties continue into older age. Autism symptoms and mental health problems were common in autistic adults, with no difference between age groups, except for anxiety, physical and eating problems. Although QoL was poorer in both younger and older autistic compared to non-autistic adults, older autistic adults reported better social QoL than those who were younger. En ligne : http://dx.doi.org/10.1002/aur.2780 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=483 Increased anticholinergic medication use in middle-aged and older autistic adults and its associations with self-reported memory difficulties and cognitive decline / Goldie A. MCQUAID in Autism Research, 17-4 (April 2024)
[article]
Titre : Increased anticholinergic medication use in middle-aged and older autistic adults and its associations with self-reported memory difficulties and cognitive decline Type de document : Texte imprimé et/ou numérique Auteurs : Goldie A. MCQUAID, Auteur ; Sean C. DUANE, Auteur ; Neha AHMED, Auteur ; Nancy Raitano LEE, Auteur ; Rebecca CHARLTON, Auteur ; Gregory L. WALLACE, Auteur Article en page(s) : p.852-867 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Abstract Many commonly used prescription and over-the-counter medicines have potent anticholinergic (AC) effects. Among older adults, AC medications are associated with cognitive impairment and risk for cognitive disorders, including Alzheimer's disease. Collectively, the impact of AC medications is known as anticholinergic cognitive burden (ACB). Because of the high rates of co-occurring medical and psychiatric conditions, autistic adults may have high AC exposure and, thus, may experience elevated ACB. However, no research has characterized AC exposure or examined its associations with cognitive outcomes in autistic adults. Autistic adults (40-83?years) recruited via Simons Powering Autism Research's (SPARK) Research Match service self-reported their medication use (N = 415) and memory complaints (N = 382) at Time (T)1. At T2, 2?years later, a subset of T1 participants (N = 197) self-reported on decline in cognition. Medications were coded using two scales of AC potency. A high proportion (48.2%-62.9%, depending upon the AC potency scale) of autistic adults reported taking at least one medication with AC effects, and 20.5% to 26.5% of autistic adults reported clinically-relevant levels of AC medication (potency ?3). After controlling for birth-sex, and age, hierarchical linear regression models showed total ACB scores and AC potency values of ?3 predicted greater memory complaints. Logistic regression models showed that AC medicines at T1 were associated with self-reported cognitive decline at follow-up 2?years later. Understanding AC medications-including potentially earlier AC polypharmacy-and their impacts on cognition (e.g., dementia risk) in autistic adults is warranted. En ligne : https://doi.org/10.1002/aur.3076 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=526
in Autism Research > 17-4 (April 2024) . - p.852-867[article] Increased anticholinergic medication use in middle-aged and older autistic adults and its associations with self-reported memory difficulties and cognitive decline [Texte imprimé et/ou numérique] / Goldie A. MCQUAID, Auteur ; Sean C. DUANE, Auteur ; Neha AHMED, Auteur ; Nancy Raitano LEE, Auteur ; Rebecca CHARLTON, Auteur ; Gregory L. WALLACE, Auteur . - p.852-867.
Langues : Anglais (eng)
in Autism Research > 17-4 (April 2024) . - p.852-867
Index. décimale : PER Périodiques Résumé : Abstract Many commonly used prescription and over-the-counter medicines have potent anticholinergic (AC) effects. Among older adults, AC medications are associated with cognitive impairment and risk for cognitive disorders, including Alzheimer's disease. Collectively, the impact of AC medications is known as anticholinergic cognitive burden (ACB). Because of the high rates of co-occurring medical and psychiatric conditions, autistic adults may have high AC exposure and, thus, may experience elevated ACB. However, no research has characterized AC exposure or examined its associations with cognitive outcomes in autistic adults. Autistic adults (40-83?years) recruited via Simons Powering Autism Research's (SPARK) Research Match service self-reported their medication use (N = 415) and memory complaints (N = 382) at Time (T)1. At T2, 2?years later, a subset of T1 participants (N = 197) self-reported on decline in cognition. Medications were coded using two scales of AC potency. A high proportion (48.2%-62.9%, depending upon the AC potency scale) of autistic adults reported taking at least one medication with AC effects, and 20.5% to 26.5% of autistic adults reported clinically-relevant levels of AC medication (potency ?3). After controlling for birth-sex, and age, hierarchical linear regression models showed total ACB scores and AC potency values of ?3 predicted greater memory complaints. Logistic regression models showed that AC medicines at T1 were associated with self-reported cognitive decline at follow-up 2?years later. Understanding AC medications-including potentially earlier AC polypharmacy-and their impacts on cognition (e.g., dementia risk) in autistic adults is warranted. En ligne : https://doi.org/10.1002/aur.3076 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=526